Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Fong

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Experientia|May 15, 1976
Alpha-tocopherol: its inhibition on human platelet aggregationJ S Fong
Medical Hypotheses|July 1, 1978
Lipid peroxidation in the hemolytic uremic syndromeS O'Regan, J S Fong
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1978
Platelet hypoaggregability in hypothyroid ratsS O'Regan, J S Fong
American Journal of Clinical Pathology|February 1, 1978
A hemolytic plate method for alternative-pathway complement activity assayJ S Fong, L Renaud
Thrombosis and Haemostasis|June 18, 1980
Reduced platelet aggregation in hemolytic-uremic syndromeB S Kaplan, J S Fong
Methods in Enzymology|January 1, 1974
Kidney glomeruliJ S Fong, K N Drummond
Birth Defects Original Article Series|January 1, 1975
Congenital and experimentally induced complement deficiency in rabbitsJ S Fong, R A Good
The Journal of Experimental Medicine|September 1, 1971
Prevention of the localized and generalized Shwartzman reactions by an anticomplementary agent, cobra venom factorJ S Fong, R A Good
Blood|September 1, 1982
Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion"J S Fong, B S Kaplan
Clinical and Experimental Immunology|January 1, 1972
Suramin--a potent reversible and competitive inhibitor of complement systemsJ S Fong, R A Good
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Experientia|May 15, 1976
Alpha-tocopherol: its inhibition on human platelet aggregationJ S Fong
Medical Hypotheses|July 1, 1978
Lipid peroxidation in the hemolytic uremic syndromeS O'Regan, J S Fong
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1978
Platelet hypoaggregability in hypothyroid ratsS O'Regan, J S Fong
American Journal of Clinical Pathology|February 1, 1978
A hemolytic plate method for alternative-pathway complement activity assayJ S Fong, L Renaud
Thrombosis and Haemostasis|June 18, 1980
Reduced platelet aggregation in hemolytic-uremic syndromeB S Kaplan, J S Fong
Methods in Enzymology|January 1, 1974
Kidney glomeruliJ S Fong, K N Drummond
Birth Defects Original Article Series|January 1, 1975
Congenital and experimentally induced complement deficiency in rabbitsJ S Fong, R A Good
The Journal of Experimental Medicine|September 1, 1971
Prevention of the localized and generalized Shwartzman reactions by an anticomplementary agent, cobra venom factorJ S Fong, R A Good
Blood|September 1, 1982
Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion"J S Fong, B S Kaplan
Clinical and Experimental Immunology|January 1, 1972
Suramin--a potent reversible and competitive inhibitor of complement systemsJ S Fong, R A Good
Pageof 4